Telehealth Enhanced Asthma Management
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- Arkansas Children's Hospital Research Institute
- Enrollment
- 15
- Locations
- 1
- Primary Endpoint
- Mean difference in ACT score at the final assessment (12 months) after adjusting for baseline
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This study will conduct a 12-month randomized trial with 48 pediatric patients (aged 6-18 years) with persistent asthma to compare outcomes among patients with follow-up visits managed via telemedicine (TM) vs. in-person (IP) visits.
Detailed Description
The overarching hypothesis is that utilization of TM for asthma follow-up will result in improved clinical outcomes such as Asthma Control Test (ACT) scores, lung function and medication adherence compared to participants receiving IP follow-up care. The Investigator also hypothesize that TM follow-up will result in higher caregiver satisfaction because families will be able to receive quality subspecialty care in their community (TM) compared to those who travel a distance to receive care (IP).
Investigators
Eligibility Criteria
Inclusion Criteria
- •age ≥6- and ≤18 years
- •persistent asthma as defined by national guidelines standards
- •receives care at an ACH asthma subspecialty clinic
- •reside ≤1.5 hour drive from Jonesboro, Springdale, Texarkana, or Fort Smith, AR
Exclusion Criteria
- •Significant underlying respiratory disease other than asthma, such as cystic fibrosis
- •significant co-morbid conditions, such as individuals with developmental or physical impairments that could interfere with the ability to communicate via interactive video
- •current smoker
- •severe asthma exacerbation requiring intubation in the past 12 months
- •no access to a smartphone or internet
Outcomes
Primary Outcomes
Mean difference in ACT score at the final assessment (12 months) after adjusting for baseline
Time Frame: At baseline and 12 months
ACT is used for symptoms monitoring as per guidelines and has been identified as an appropriate asthma control composite score in clinical research.
Secondary Outcomes
- Airway Inflammation via Spirometry(Baseline and 12 months)
- Healthcare Utilization(At baseline, 4 months, 8 months, 12 months)
- Routine Follow up Asthma Visit(At baseline, 4 months, 8 months, 12 months)
- Lung Function via Spirometry(Baseline and 12 months)
- Medication Adherence(At baseline, 4 months, 8 months, 12 months)
- Rescue Medication Use(At baseline, 4 months, 8 months, 12 months)
- Clinic Visit Attendance Rate(At baseline, 4 months, 8 months, 12 months)
- Visit Satisfaction(At baseline, 4 months, 8 months, 12 months)